High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Pulling $54,000 a year from a $950,000 rollover IRA sounds like a math problem, but the real trap is hidden in the yield tier you choose and what it quietly does to your principal over time.
Universal Corp just cratered to a fresh 52-week low while rival tobacco stocks barely flinched, raising an urgent question about whether this leaf tobacco supplier is facing a problem all its own.
MO's smoke-free push gains traction as on! PLUS expands distribution, retail share and product choice in a growing nicotine pouch category.
A smaller portfolio built around the right income assets can throw off more cash every year than a million dollars sitting in the S&P 500, but the tradeoffs between each yield tier will determine whether that income grows or quietly erodes.
Second-quarter earnings season shook loose some rare discounts on five high-yield dividend stocks that Wall Street analysts still rate as Buys, and income-focused investors may not get another shot at these prices.
While Altria Group has underperformed the broader market over the past year, analysts remain moderately optimistic about its future growth prospects.
The agency greenlit the products as part of a pilot program aimed at shortening approval times.
With inflation still biting into real yields and Q3 cash flow season approaching fast, five income stalwarts stand out as the dividend payers retirees keep reaching for when the calendar turns to fall.
The nicotine pouch brand, which received marketing approval from the FDA for multiple varieties in late 2025, expanded to 120,000 stores nationwide.
Chasing the highest dividend yield feels like the fastest path to $1,500 a month in passive income, but the math reveals a compounding trap that catches most income investors off guard.
SCHD charges just 0.06% per year, but taxable investors who lived through the March reconstitution discovered a second bill arriving in a very different form. Here is what the expense ratio line was never designed to show you.
EPS grew 2.8% as Marlboro pricing offset volume declines and oral tobacco expanded.
MO's pricing power supports smokeable revenues and profit despite declining cigarette volumes and a growing shift toward discount brands.
Levi & Korsinsky has opened an investigation into Altria Group regarding disclosures tied to the FDA regulatory status of its on! PLUS nicotine pouch product. The review focuses on whether Altria accurately described near term FDA authorization prospects for on! PLUS in its public statements. This action introduces an additional legal and regulatory consideration for investors following NYSE:MO. Altria Group, trading under NYSE:MO, now faces questions around its communication practices at a...
Tobacco company Altria (NYSE:MO) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.2% year on year to $5.36 billion. Its non-GAAP profit of $1.48 per share was 1.2% below analysts’ consensus estimates.
Altria Group (NYSE:MO) reported higher adjusted earnings for the second quarter and first half of 2026, supported by pricing in its smokable-products business, growth in its nicotine pouch portfolio and continued shareholder returns. The company raised the lower end of its full-year adjusted earning
Both readings are true at once, and the gap between them is the real question for anyone weighing the shares.
Sin stock sectors, including alcohol, tobacco, cannabis, firearms and gambling, attract investors with resilient cash flows, pricing power and defensive demand despite regulatory, litigation and ESG risks.
MO highlights on! PLUS expansion, smoke-free growth plans and shareholder returns as it narrows 2026 earnings outlook.
Moby summary of Altria Group, Inc.'s Q2 2026 earnings call
EPS grew 2.8% as Marlboro pricing offset volume declines and oral tobacco expanded.
Altria Group Inc (MO) delivered a 4.9% adjusted EPS increase and expanded On+ to 120,000 stores, while navigating consumer trade-downs and intensified nicotine pouch competition.
Investors are seeing warning signs in Altria's Q2 report.
MO's second-quarter earnings miss estimates as cigarette shipments fall, though higher pricing lifted smokeable products revenues and supported profit growth.
Altria Group Inc. (NYSE:MO) shares fell nearly 4% after the tobacco company reported second-quarter earnings that came in slightly below Wall Street expectations, despite revenue exceeding forecasts.
The headline numbers for Altria (MO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tobacco company Altria (NYSE:MO) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 15.5% year on year to $6.11 billion. Its non-GAAP profit of $1.48 per share was 1.2% below analysts’ consensus estimates.
Altria (MO) delivered earnings and revenue surprises of -1.33% and -0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
